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0.18700.0191units/ml). There were strong positive signals of PKCa
both in the intima and in the media closely abuted with the intima.
Further in vitro experiment discovered that modiﬁed LDL signiﬁ-
cantly increased cytomembrane PKC activity in HASMC, HAEC and
THP-1, and that 100nmol/l PMA (PKC agonist) could synergistically
enhance the expressions of ICAM-1 and ezrin in the presence of
oxidized LDL (oxLDL, a key modiﬁed LDL); However, it reduced the
content of I-kBa. Together with oxLDL, PMA stimulated the adhesion
ability of endothelial cells with monocytes. 300nmol/lCalphostin C
(PKC inhibitor) could ultimately reverse the effects induced by 50mg/
ml oxLDL, that is to say, PKC activity, the expression of ICAM-1 and
ezrin, and the adhesion ability of HAEC cells were down-regulated,
respectively, whereas the content of I-kBa was increased. Similarly
with the effects of oxLDL, enzymatically modiﬁed LDL (E-LDL, a key
modiﬁed LDL) increased the adhesion ability of endothelial cells with
monocytes in a dose-dependent manner and the ideal dose of E-LDL
is 20-40mg/ml. 200-400nml/l Calphostin C ultimately reverse the
effects induced by E-LDL. ICAM-1 and I-kBa may mediate the corre-
sponding pathological process.
CONCLUSIONS The pathway of PMA/Calphostin C - PKC- NF-kB/I-
kB -ICAM-1-Adherence may be an important one through which
the adherent information was conveyed and integrated. In addi-
tion, the pathway adhesion molecules-ezrin-cytoskeleton may
enhance the adhesion interaction of endothelial cells with mono-
cytes. Calphostin C could effectively inhibited the increase of the
adhesion ability of endothelial cells with monocytes induced by
modiﬁed LDL.GW26-e0807
Multimodality Molecular Imaging Monitors Bone Marrow Mesenchymal
Stem Cells for the Treatment of Ischemic Heart Disease in Rats
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OBJECTIVES The aim of this study was to explore multimodality
molecular imaging to monitor transplanted stem cells with a triple-
fused reporter gene in acute myocardial infarction rat models.
METHODS Rat myocardial infarction was established by ligating the
left anterior descending coronary artery. A recombinant adenovirus
carrying TGF (Ad5-TGF) was constructed. After transfection with
Ad5-TGF, 5  10(6) bone marrow mesenchymal stem cells (BMSCs)
were transplanted into the anterior wall of the left ventricle
(n ¼ 14). Untransfected BMSCs were as controls (n ¼ 8). MicroPET/
CT, ﬂuorescence and bioluminescence imaging were performed.
Continuous images were obtained at day 2, 3 and 7 after trans-
plantation with all three imaging modalities and additional images
were performed with bioluminescence imaging until day 15 after
transplantation.
RESULTS High signals in the heart area were observed using
microPET/CT, ﬂuorescence and bioluminescence imaging of in-
farcted rats injected with Ad5-TGF-transfected BMSCs, whereas no
signals were observed in controls. Semi-quantitative analysis showed
the gradual decrease of signals in all three imaging modalities with
time. Immunohistochemistry assays conﬁrmed the location of the
TGF protein expression was the same as the site of stem cell-speciﬁc
marker expression, suggesting that TGF tracked the stem cells in
situ.
CONCLUSIONS TGF could be used as a reporter gene to monitor stem
cells in a myocardial infarction model by multimodality molecular
imaging.
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OBJECTIVES miR-126 is considered to play an active role in car-
dioprotection against ischemia/reperfusion (I/R) injury, as studies
suggest that it facilitates vascular regeneration and ameliorates
myocardial I/R injury by modulating angiogenic signaling. In thisstudy, the critical role of miR-126 in cardiomyocyte survival and the
underlying molecular mechanism were investigated.
METHODS Male Wistar rats were randomly divided into sham opera-
tion group and I/R group (in which the left anterior descending cor-
onary artery of the rats were ligated for 30 min and then reperfused
for 120 min). Lentivirus expressing miR-126 (LmiR-126) was con-
structed and transfected into rat through the right common carotid
artery. Western blotting and quantitative PCR methods were applied
to detect protein and mRNA expressions. Myocardial apoptosis and
infarct size were analyzed by in situ apoptosis assay and triphe-
nyltetrazolium chloride (TTC) staining, respectively.
RESULTS Our study demonstrated that the expression of miR-126
was decreased in I/R group compared with sham operation group
(p<0.01). Stretch or enforced expression of miR-126 signiﬁcantly
decreased I/R-induced myocardial infarct size by 42% and attenu-
ated I/R-induced myocardial apoptosis, together with down-regu-
lation of glycogen synthase kinase 3 beta (GSK-3b) (p<0.05). The
results of luciferase assays suggested that GSK-3b may be a direct
target of miR-126. Knockdown of GSK-3b inhibited cell apoptosis
and afforded cardioprotection during I/R injury, while its over-
expression abolished the effects of miR-126. In addition, miR-126
increased both protein and mRNA levels of b-catenin, which is the
downstream effector of GSK-3b in Wnt/b-catenin signaling pathway,
and subsequently elevated the expressions of b-catenin targets
cyclin D1 and c-Myc.
CONCLUSIONS These ﬁndings illustrated that miR-126 played
an important role in cardioprotection against I/R injury through tar-
geting GSK-3b and subsequently activating Wnt/b-catenin signaling
pathway.GW26-e1435
Tanshinone IIA Reduces Atrial Fibrillation by Inhibiting Left Atrial Fibrosis
Via MMP-9 / TIMP-1 Pathway in Isoproterenol-Induced Myocardial
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OBJECTIVES Atrial ﬁbrosis is a major contributing factor of atrial
ﬁbrillation (AF). Tanshinone IIA (TSN) is a lipophilic diterpene
extracted from the Chinese herb Salvia miltiorrhiza Bunge with anti-
ﬁbrotic effect. We used isoproterenol-induced myocardial infarction
(MI) rats together with transesophageal programmed electrical stim-
ulation AF inducing technology to investigate the effects of TSN on AF
and the underlying mechanisms.
METHODS MI rat model was induced by isoproterenol. One week after
the ﬁrst injection, 100 mg/Kg/d TSN was gavaged for 4 weeks. AF
inducibility and duration were detected by transesophageal pro-
grammed electrical stimulation AF inducing technology. The expres-
sion of I and III collagen and the change of MMP-9/TIMP-1 balance in
left atrial were measured by western blot.
RESULTS After 2 hours of injection isoproterenol, the ST segment
elevated and serum CK-MB levels increased. Four weeks after the
administration of TSN, the AF inducibility was lower than the MI
group (47.1% in TSN vs. 70.6% in MI) and the AF duration was reduced
(88.1-257.4s in TSN vs. 441.5-1317.5s in MI, P <0.05). Type I (0.950.08
in TSN vs. 1.690.14 in MI, P<0.05) and III (1.950.20 in TSN vs.
3.190.36 in MI, P<0.05) collagen in left atrium were decreased in
administration group, compared with MI group. The matrix metal-
loproteinase (MMP)-9 and tissue inhibitor of metalloproteinase 1
(TIMP-1) protein levels were lower than MI group, MMP-9/TIMP-1
ratio (0.20 in TSN vs. 0.27 in MI) decreased.
CONCLUSIONS TSN reduces the inducibility rate and duration of AF
after MI by inhibiting left atrial ﬁbrosis via regulating MMP-9 / TIMP-1
balance.GW26-e1522
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OBJECTIVES Cardiac ﬁbrosis is a common feature of advanced
coronary heart disease and is also a hallmark of heart diseases.
J O U R N A L O F T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y , V O L . 6 6 , N O . 1 6 , S U P P L S , 2 0 1 5 C41However, currently available drugs against cardiac ﬁbrosis are still
very limited. Ginkgo biloba extract 761 (EGb 761) is a well-deﬁned
extract obtained from Ginkgo biloba leaves according to a stan-
dardized method. It has been used extensively for the treatment of
diseases related to the memory impairment, stroke, inﬂammation,
and vasooclusive disorders. Consequently, a potential use of EGb
761 in liver ﬁbrosis has been proposed. However, no study has
proved whether EGb 761 can prevent cardiac ﬁbrosis after myocar-
dial infarction. Therefore, this study was performed to investigate
the role of EGb 761 in the myocardial ﬁbrosis in a rat model of
myocardial infarction.
METHODS Adult male SD rats were randomly divided into three
groups: sham group, myocardial infarction group, and myocardial
infarctionþEGb 761 group. According to the doses of EGb 761,
myocardial infarctionþEGb 761 group was divided into three
subgroups: 25 mg/kg, 50 mg/kg, and 100 mg/kg groups. The left
anterior descending coronary artery was permanently ligated in
the myocardial infarction and myocardial infarctionþEGb 761
groups. The sham-operated group was subjected to all procedures
excluding permanent coronary artery ligation. The effects of EGb
761 on the cardiac function and cardiac ﬁbrosis after myocardial
infarction were observed by echocardiography and histological
analyses.
RESULTS Compared with the sham group rats, left ventricular in-
ternal dimension diastole (LVIDd) and left ventricular internal
dimension systole (LVIDs) increased, ejection fraction (EF) and
fractional shortening (FS) decreased in the myocardial infarction
group rats. Notably, LVIDd and LVIDs were signiﬁcantly decreased,
whereas EF and FS were signiﬁcantly improved in the EGb 761
treated rats relative to the myocardial infarction alone rats. Patho-
logical analysis revealed that no blue area and inﬂammatory cell
inﬁltrate was detected in the sham group. In contrast, the infarcted
zone in the myocardial infarction group was ﬁlled with blue scar
tissues. And there were a lot of inﬂammatory cells inﬁltration.
However, administration of EGb 761 reduced the area stained blue
and inﬁltration of inﬂammatory cells compared with myocardial
infarction group. Meanwhile, the effect of 100 mg/kg EGb 761 was
more pronounced.
CONCLUSIONS Our study suggested that EGb 761 could reduce
myocardial ﬁbrosis and improve cardiac function after myocardial
infarction.GW26-e2177
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OBJECTIVES Proprotein convertase subtilisin-like kexin type 9
(PCSK9) gene E670G Polymorphism has been reported to be associated
with coronary artery disease (CAD) and risk factors. However, the
results remain controversial. We sought to perform a meta-analysis to
investigate the relationships between genetic polymorphisms of
PCSK9 gene and the risk of CAD.
METHODS Literature searches were performed to identify all pub-
lished relevant case-control studies without any language restrictions.
Meta-analysis was conducted using the Review Manager software
(version5.2). Heterogeneity was investigated and measured using
Cochran’s Q-statistic and the inconsistency index (I2) test; Crude odds
ratios (OR) with their corresponding 95% conﬁdence interval (CI) were
calculated.
RESULTS A total of 5 case-control studies among 871 patients with
CAD and 1144 control subjects were included in the meta-analysis.
we found a correlation between PCSK9 genetic polymorphisms and
increased risk for CAD under all of the genetic model (allele model:
OR 1.56, 95% CI 1.21-2.01, P < 0.001; dominant model: OR 1.46, 95%
CI 1.14-1.88, P ¼ 0.003; recessive model: OR 3.46, 95% CI 1.19-
10.10, P ¼ 0.02; homozygous model: OR 3.89, 95% CI 1.35-11.20, P ¼
0.01; Heterozygous model: OR 1.43, 95% CI 1.08-1.92, P ¼ 0.01;
respectively).
CONCLUSIONS The results of the meta-analysis indicated that ge-
netic polymorphism of (E670G) SNP in PCSK9 gene was associated
with CAD.GW26-e2249
Antioxidative Activity of Salvianolic Acid B and Tanshinone IIA, Panax
Notoginseng Saponin on Isoproterenol Induced Myocardial Infarction
in Rats
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OBJECTIVES The oxidative stress play a major role in the pathogen-
esis of acute myocardial infarction (AMI). Early inhibition of oxidative
stress may improve post MI cardiac function. The aim of this study
was to investigate and compare the effects of Panax Notoginseng and
Salvia Miltiorrhiza on cardiac function, infarction size as well as his-
topathologic and electrocardiographic changes in isoproterenol-
induced myocardial infarction.
METHODS Salvianolic Acid B and Tanshinone IIA, Panax Notoginseng
Saponin (20 mg kg-1) were administered to Wistar rats for 14 days. At
the last two days, rats were administered isoproterenol (85mg kg-1)
subcutaneously to induce myocardial infarction. After induction, rats
were anaesthetized with pentobarbital sodium (30 mg kg-1) to record
electrocardiogram and Echocardiographic image, then sacriﬁced and
biochemical assays of the heart tissues were performed.
RESULTS Administration of isoproterenol resulted in myocardial
infarction marked (P <0.05) elevation in J-Point, infarct size, MDA,
protein expression of Bax and a signiﬁcant decrease in the activities of
endogenous antioxidants (SOD) and protein expression of Bcl-2 and
Nrf2. Pretreatment with Salvianolic Acid B and Tanshinone IIA, Panax
Notoginseng Saponin showed a signiﬁcant (P <0.05) decrease in
J-point elevation, infarct size, MDA, protein expression of Bax and a
signiﬁcant increase in the activities of endogenous antioxidants and
protein expression of Bcl-2 and Nrf2 except for Salvianolic Acid B,
where is the major difference between Salvia Miltiorrhiza and Panax
Notoginseng, when compared with ISO groups.
CONCLUSIONS The results of this study showed that pretreatment
with Salvianolic Acid B, Tanshinone IIA and Panax Notoginseng
Saponin strongly protected the myocardium against the isoproter-
enol-induced myocardial injury; where this might be due to the
antioxidative properties of Salvianolic Acid B and Tanshinone IIA,
Panax Notoginseng Saponin.
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OBJECTIVES GP78 is a membrane-anchored ubiquitin ligase medi-
ating the degradation of 3-hydroxy-3-methyl-glutaryl-CoA coenzyme
A reductase (HMGCR) and Insig-1, which was very essential for the
synthesis of cholesterol and glucose process. Dysregulation of lipid
and glucose homeostasis is a risk factor for developing conditions
linked to type 2 diabetes mellitus. The aim of the present study was to
assess the association between the human gp78 gene polymorphism
and type 2 diabetes mellitus (T2DM) in a Han population of China.
METHODS We used case-control studies: a Han population (450 T2DM
patients and 480control subjects). All T2DM patients and controls
were genotyped for the same three single nucleotide polymorphisms
(SNPs) (rs731119, rs2617849and rs2440472) of gp78 gene by a Real-time
PCR instrument.
RESULTS The genotype distributions for each of the SNPs were in
agreement with the predicted Hardy–Weinberg equilibrium values
(data not shown). The distribution of SNP2 (rs2617849) genotypes
showed a signiﬁcant difference between T2DM and control partici-
pants (P¼0.038). the distribution of SNP2 (rs2617849) alleles and the
dominant model (TT vs CCþCT) showed a signiﬁcant difference be-
tween T2DM and control participants (for allele: P¼0.021; for domi-
nant model: P¼0.017 ). T allele of rs2617849 was signiﬁcantly higher in
T2DM patients than in control participants (73% vs 62.5%). And the C
allele of rs2617849 was signiﬁcantly lower in T2DM patients than in
control participants (27% vs 37.5). The dominant model (TTvsCCþCT)
of rs2617849 was signiﬁcantly higher in T2DM patients than in control
participants (57.8% vs 45.8%). The signiﬁcant difference of rs2617849
was retained after adjustment for EH, BMI, LDL, and smoking.
(OR: 1.461, 95% conﬁdence interval [CI]: 1.084-1.991, P¼0.032).
